Hopp til innhold

Valgte elementer er lagt i handlekurven

Gå til handlekurv
Artikkel
Reseptregisteret:

Vitenskapelige publikasjoner basert på data fra Reseptregisteret

Liste over vitenskapelige publikasjoner basert på data fra Reseptregisteret per mars 2017 / List of publications based on data from the Norwegian Prescription Database (NorPD) as of March 2017

Colourbox.com
Colourbox.com

2017

Efjestad AS, Ihle-Hansen H, Hjellvik V,  Blix HS. Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors. Dement Geriatr Cogn Disord Extra 2017;7: 30–40.

Engeland A, Bjørge T, Klungsøyr K, Skurtveit S, Furu K. Preterm births and use of medication in early adulthood: a population-based registry study. Pharmacoepidemiol Drug Saf. 2017 Feb 7. doi: 10.1002/pds.4174. [Epub ahead of print]

Fredheim OM, Brelin S, Hjermstad M J, Loge JH, Aass N, Johannesen TB, Skurtveit S. Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009. Eur J Pain 2017;21(3), 530-40.

Furu K, Karlstad Ø, Zoega H, Martikainen J, Bahmanyar S, Kieler H, Pottegård A. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 million Children Using Population-based Longitudinal Data.  Basic Clin Pharmacol Toxicol 2017;120(4):373-9.

Graner S, Svensson T, Beau AB, Damase-Michel C, Engeland A, Furu K, Hviid A, Håberg SE, Mølgaard-Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy, and the risk of adverse neonatal outcomes and congenital malformations-A population based European register study. BMJ 2017. Mar 1;356:j629.

Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants. Eur Heart J Cardiovasc Pharmacother 2017;3(1), 28-36.

Instanes JT,Halmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K. Attention-deficit/
hyperactivity disorder in offspring of mothers with inflammatory and Immune system diseases, Biological Psychiatry Biol Psychiatry. 2017;81(5):452-9

Johannsdottir IM, Karlstad Ø, Loge JH, Fossa SD, Kiserud C, Skurtveit S. Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study. J Adolesc Young Adult Oncol 2017;6(1), 120-6.

Jørgensen SB, Søraas A, Sundsfjord A, Liestøl K, Leegaard TM, Jenum PA. Fecal carriage of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study. PLoS ONE 2017;12(3), e0173510.

Modalsli, EH, Åsvold BO, Romundstad PR, Langhammer A, Hoff M, Forsmo S, Naldi L, Saunes M. Psoriasis, fracture risk and bone mineral density: The HUNT Study, Norway. Br J Derm 2017;March 15. doi:http://dx.doi.org/10.1111/bjd.15123

Odsbu I, Selmer R, Lundborg CS, Blix HS. Increased prescribing of systemic tetracyclines and isotretinoin for treatment of acne. J Antimicrob Chemother 2017 dkw586. doi: 10.1093/jac/dkw586. 

Parr CL, Magnus MC, Karlstad Ø, Haugen M, Refsum H, Ueland PM, McCann A, Nafstad P, Håberg SE, Nystad W, London SJ. Maternal folate intake during pregnancy and childhood asthma in a population-based cohort. Am J Respir Crit Care Med 2017;195(2), 221-8.

Raknes G, Småbrekke L. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study. Pharmacoepidemiol Drug Saf 2017; 26(2), 136-142.

Reigstad MM, Storeng R, Myklebust TA, Oldereid NB, Omland AK, Robsahm TE, Brinton LA, Vangen S, Furu K, Larsen IK. Cancer Risk in Women Treated with Fertility Drugs According to Parity status - A Registry-based Cohort Study. Cancer Epidemiol Biomarkers Prev 2017 Jan 20. DOI: 10.1158/1055-9965.EPI-16-0809 [Epub ahead of print].

Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel A, Gustavsen I, Mørland J, Skurtveit S. Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids. Basic Clin Pharmacol Toxicol 2017; 120(3), 292-8.

Svendsen T, Brodtkorb E, Reimers A, Molden E, Saetre E, Johannessen S I, Johannessen Landmark, C. Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome. Epilepsy Res 2017;129, 125-31.

Svendsen T, Brodtkorb E, Baftiu A, Burns ML, Johannessen SI, Johannessen Landmark C. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability. Neurochem Res. 2017 Mar 27. doi: 10.1007/s11064-017-2234-8. [Epub ahead of print]

Youngster I, Avorn J, Belleudi V, Cantarutti A, Díez-Domingo J, Kirchmayer U, Park BJ, Peiró S, Sanfélix-Gimeno G, Schröder H, Schüssel K, Shin JY, Shin SM, Simonsen GS, Blix HS, Tong A, Trifirò G, Ziv-Baran T, Kim SC. Antibiotic use in children – a cross-national anlysis of 6 countries. J Pediatr 2017;182:239-44.

2016

Andenaes R, Helseth S, Misvaer N, Småstuen MC, Ribu L. Psychosocial factors are strongly associated with insomnia in users and nonusers of prescribed sleep medication: Evidence from the HUNT3 study. J Multidisciplinary Healthcare 2016;9:547-55.

Baftiu A, Johannessen Landmark C, Rusten IR, Feet SA, Johannessen SI, Larsson PG. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications. Eur J Clin Pharmacol 2016;72(10):1245-54.

Bains SJ, Mahic M, Myklebust TA, Smastuen MC, Yaqub S, Dorum LM, et al. Aspirin as secondary prevention in patients with colorectal cancer: An unselected population-based study. J Clin Oncol 2016;34(21):2501-8.

Bakken MS, Schjøtt J, Engeland A, Engesaeter LB, Ruths S. Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway. J Am Geriatr Soc 2016;64(6):1203-9.

Blagestad T, Nordhus IH, Gronli J, Engesaeter LB, Ruths S, Ranhoff AH, et al. Prescription trajectories and effect of total hip arthroplasty on the use of analgesics, hypnotics, antidepressants, and anxiolytics: Results from a population of total hip arthroplasty patients. Pain 2016;157(3):643-51.

Brelin S, Fredheim OM, Loge JH, Skurtveit S, Johannesen TB, Aass N, et al. Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study. Journal of Opioid Management 2016;12(1):25-36.

Charlton RA, Klungsøyr K, Neville AJ, Jordan S, Pierini A, de Jong-van den Berg LTW, et al. Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions. PLoS One 2016; May 18;11(5): e0155737. doi: 10.1371/journal.pone.0155737.

Charlton RA, Pierini A, Klungsøyr K, Neville AJ, Jordan S, de Jong-van den Berg LT, et al. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open 2016 Jan 19;6(1):e009237.

leiner HF, Bjoro T, Midthjell K, Grill V, Asvold BO. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: The population-based hunt study in Norway. J Clin Endocrinol Metab 2016;101(2):669-77.

Gabrhelik R, Nechanska B, Mravcik V, Skurtveit S, Lund IO, Handal M. A Unique Opportunity to Study Short and Long Term Consequences in Children Prenatally Exposed to Illicit Drugs and Opioid Maintenance Treatment Using Czech and Scandinavian Registers. Cent Eur J Public Health 2016;24(3):248-51.

Garne E, Vinkel Hansen A, Morris J, Jordan S, Klungsøyr K, Engeland A, et al. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study. BJOG 2016;123(10):1609-18.

Gimeno-Feliu LA, Calderon-Larranaga A, Prados-Torres A, Revilla-Lopez C, Diaz E. Patterns of pharmaceutical use for immigrants to Spain and Norway: a comparative study of prescription databases in two European countries. International Journal for Equity in Health 2016;15.

Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction. BMC Cardiovasc Disord 2016;16:115.

Hartz I, Skurtveit S, Hjellvik V, Furu K, Nesvåg R, Handal M. Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study. Acta Psychiatr Scand 2016;134(5):420-9.

Hartz I, Skurtveit S, Steffenak AK, Karlstad Ø, Handal M. Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study. BMC Psychiatry 2016;16:12.

Johannsdottir IM, Karlstad Ø, Loge JH, Fossa SD, Kiserud C, Skurtveit S. Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study. J Adolesc Young Adult Oncol 2016;14:14.

Jordan S, Morris JK, Davies GI, Tucker D, Thayer DS, Luteijn JM, et al. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark. PLoS One 2016;11(12):e0165122.

Karlstad Ø, Zoega H, Furu K, Bahmanyar S, Martikainen JE, Kieler H, et al. Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries. Eur J Clin Pharmacol 2016;72(12):1507-14.

Kaspersen SL, Pape K, Ose SO, Gunnell D, Bjorngaard JH. Unemployment and initiation of psychotropic medication: a case-crossover study of 2 348 552 Norwegian employees. Occup Environ Med 2016;73(11):719-26.

Kjaerulff TM, Ersboll AK, Green A, Emneus M, Pukkala E, Bolin K, et al. Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study. Scand J Urol 2016;50(3):220-7.

Knudsen-Baas KM, Engeland A, Gilhus NE, Storstein AM, Owe JF. Does the choice of antiepileptic drug affect survival in glioblastoma patients? J Neurooncol 2016;129(3):461-9.

Kravdal Ø, Grundy E. Health effects of parental deaths among adults in Norway: Purchases of prescription medicine before and after bereavement. SSM - Population Health 2016;2:868-75.

Magnus MC, Håberg SE, Magnus P, Engeland A, Nafstad P, Karlstad Ø, et al. Pre-eclampsia and childhood asthma. Eur Respir J 2016;48(6):1622-30.

Magnus MC, Karlstad Ø, Håberg SE, Nafstad P, Davey Smith G, Nystad W. Prenatal and infant paracetamol exposure and development of asthma: The Norwegian Mother and Child Cohort Study. Int J Epidemiol 2016;45(2):512-22.

Magnus MC, Karlstad Ø, Midtun O, Håberg SE, Tunheim G, Parr CL, et al. Maternal plasma total neopterin and kynurenine/tryptophan levels during pregnancy in relation to asthma development in the offspring. J Allergy Clin Immunol 2016;138(5):1319-25.e4.

Magnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, Handal M, Haugen M, Høiseth G, Knudsen GP, Paltiel L, Schreuder P, Tambs K, Vold L, Stoltenberg C. Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2016;45(2):382-8.

 

Mellbye A, Borchgrevink PC, Skurtveit S, Fredheim OMS. Hva vet vi om bruken av opioider ved ikke-malign smerte? Norsk farmaceutisk tidsskrift 2016;(3):25-30.

 

Mellbye A, Karlstad Ø, Skurtveit S, Borchgrevink PC, Fredheim OMS. The duration and course of opioid therapy in patients with chronic non-malignant pain. Acta Anaesthesiol Scand 2016;60:128-37.

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O. Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PLoS One 2016;11(11):e0166451.

Nesvåg R, Hartz I, Bramness JG, Hjellvik V, Handal M, Skurtveit S. Mental disorder diagnoses among children and adolescents who use antipsychotic drugs. Eur Neuropsychopharmacol 2016;26:1412-8.

Olah KS, Kim TH, Lee HH, Kim JM. Re: Use of hormonal contraceptives among immigrant and native women in Norway: data from the Norwegian Prescription Database The contraceptive situation in Korea. BJOG 2016;123(5):840.

Roman M, Graff-Iversen S, Weiderpass E, Vangen S, Sakshaug S, Hofvind S, et al. Postmenopausal hormone therapy and breast cancer prognostic characteristics: A linkage between nationwide registries. Cancer Epidemiology Biomarkers and Prevention 2016;25(11):1464-73.

Roman M, Sakshaug S, Graff-Iversen S, Vangen S, Weiderpass E, Ursin G, et al. Postmenopausal hormone therapy and the risk of breast cancer in Norway. Int J Cancer 2016;138(3):584-93.

Samuelsen PJ, Svendsen K, Wilsgaard T, Stubhaug A, Nielsen CS, Eggen AE. Persistent analgesic use and the association with chronic pain and other risk factors in the population-a longitudinal study from the Tromso Study and the Norwegian Prescription Database. Eur J Clin Pharmacol 2016;72:977-85.

Selmer R, Haglund B, Furu K, Andersen M, Norgaard M, Zoega H, et al. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy. Pharmacoepidemiol Drug Saf 2016;25(10):1160-9.

Skipenes VP, Skjeldestad FE. Prevalence of combined contraceptive vaginal rings in Norway. Acta Obstet Gynecol Scand 2016;95(9):1027-33.

Sørensen M, Arneberg F, Line TM, Berg TJ. Cost of diabetes in Norway 2011. Diabetes Res Clin Pract 2016;122:124-32.

Straiton ML, Reneflot A, Diaz E. Mental Health of Refugees and Non-refugees from War-Conflict Countries: Data from Primary Healthcare Services and the Norwegian Prescription Database. J Immigr Minor Health 2016;21:21.

Tjagvad C, Skurtveit S, Bramness JG, Gjersing L, Gossop M, Clausen T. Misuse of prescription drugs and overdose deaths. Journal of Substance Use 2016;21(5):515-20.

Tvete IF, Bjørner T, Skomedal T. A 5-year follow-up study of users of benzodiazepine: Starting with diazepam versus oxazepam. Br J Gen Pract 2016;66(645):e241-e7.

Øvre-Eide V, Skjeldestad FE. Use pattern for contraceptive implants in Norway. Acta Obstet Gynecol Scand 2016;95(11):1244-50.

 

2015

Berg C, Skurtveit S, Sakshaug S, Hjellvik V, Handal M. Reduced Prescribing of Benzodiazepines in Denmark and Norway. Basic Clin Pharmacol Toxicol. 2015;116(6):457-8.

Blix HS, Vestrheim DF, Hjellvik V, Skaare D, Christensen A, Steinbakk M. Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance? Epidemiology and Infection. 2015;143(9):1884-92. doi: 10.1017/S0950268814002908

Bukten A, Lund IO, Rognli EB, Stavseth MR, Lobmaier P, Skurtveit S, Clausen T, Kunøe N. The Norwegian Offender Mental Health and Addiction Study - Design and Implementation of a National Survey and Prospective Cohort Study. Subst Abuse. 2015;9(Suppl 2):59-66. doi: 10.4137/SaRt.S23546. eCollection 2015.

Charlton R, Garne E, Wang H, Klungsøyr K, Jordan S, Neville A, Pierini A, Hansen A, Engeland A et al. Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions. Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1144-54. doi: 10.1002/pds.3847.

Dale O, Borchgrevink PC, Fredheim OM, Mahic M, Romundstad P, Skurtveit S. Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids. BMC Public Health. 2015;15:461. doi: 10.1186/s12889-015-1774-6

de Jonge L, Garne E, Gini R, Jordan SE, Klungsoyr K, Loane M, et al. Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study. Drug safety. 2015;38(11):1083-93. doi:  10.1007/s40264-015-0321-9

Engeland A, Bjørge T, Klungsøyr K, Skjaerven R, Skurtveit S, Furu K. Preeclampsia in pregnancy and later use of antihypertensive drugs. European Journal of Epidemiology. 2015;30(6):501-8. doi: 10.1007/s10654–015 – 0018–5.

Fredheim OMS, Mahic M, Skurtveit S, Borchgrevink PC. Use of nasal fentanyl for cancer pain: A pharmacoepidemiological study. Palliative Medicine. 2015;29(7):661-6. doi: 10.1177/0269216315575252

Fride Tvete I, Bjørner T, Skomedal T. Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway. Scand J Prim Health Care. 2015;33(4):252-9. doi: 10.3109/02813432.2015.

Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir U,  Zoega H,  Artama M, Gissler M, Malm H, Nørgaard M. Serotonin-Reuptake Inhibitors and Venlafaxine in early pregnancy and risk of birth defects – a population based cohort study and sibling design. BMJ 2015. Apr 17;350:h1798.

Hagen TP, Hakkinen U, Iversen T, Klitkou So T, Moger TA. Socio-economic inequality in the use of procedures and mortality among AMI patients: Quantifying the effects along different paths. Health Econ. 2015;24:102-15. doi: 10.1002/hec.3269.

Halvorsen T, Martinussen PE. Benzodiazepine use in COPD: empirical evidence from Norway. Int  J Chron Obstruct Pulmon Dis 2015;10:1695-702. doi: 10.2147/COPD.S83107

Hansen AB, Skurtveit S, Borchgrevink PC, Dale O, Romundstad PR, Mahic M, et al. Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain. Acta Anaesthesiologica Scandinavica. 2015;59(10):1355-66. doi: 10.1111/aas.12645

Hartz I, Handal M, Tverdal A, Skurtveit S. Paediatric Off-Label Use of Melatonin - A Register Linkage Study between the Norwegian Prescription Database and Patient Register. Basic Clinl Pharmacol Toxicol 2015;117(4):267-73. doi: 10.1111/bcpt.12411

Hermann M, Waade RB, Molden E. Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients. Therapeutic Drug Monitoring. 2015;37(4):546-9. doi: 10.1097/FTD.0000000000000169.

Hoff M, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, et al. Use of anti-osteoporotic drugs in central Norway after a forearm fracture. Archives of Osteoporosis. 2015;10:30.  doi: 10.1007/s11657-015-0235-2.

Høiseth G, Middelkoop G, Mørland J, Gjerde H. Has Previous Abuse of Flunitrazepam Been Replaced by Clonazepam? European Addiction Research. 2015;21(4):217-21. DOI:10.1159/000377628

Iversen MM, Nefs G, Tell GS, Espehaug B, Midthjell K, Graue M, et al. Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: Nine-year follow-up of the Nord-Trøndelag Health Study, Norway. Journal of Psychosomatic Research. 2015;79(4):309-15.

Jensen ET, Daniels JL, Sturmer T, Robinson WR, Williams CJ, Vejrup K, et al. Hormonal contraceptive use before and after conception in relation to preterm birth and small for gestational age: An observational cohort study. BJOG 2015;122(10):1349-61. DOI: 10.1111/1471-0528.13114

Johannessen Landmark C, Beiske G, Baftiu A, Burns ML, Johannessen SI. Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice. Seizure. 2015;28:88-91. doi:10.1016/j.seizure.2015.02.017

Kann IC, Lundqvist C, Lurås H. Polypharmacy Among the Elderly in a List-Patient System. Drugs - Real World Outcomes. 2015;2(3):193-8. doi: 10.1007/s40801-015-0036-3

Kelly E, Lu CY, Albertini S, Vitry A. Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison. Journal of Clinical Pharmacy and Therapeutics. 2015;40(1):76-82. doi: 10.1111/jcpt.12227

Kieler H, Malm H, Artama M, Engeland A, Furu K, Gissler M, et al. Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG-an International Journal of Obstetrics and Gynaecology. 2015;122(12):1618-24. DOI: 10.1111/1471-0528.13164

Kravdal Ø, Grundy E, Skirbekk V. Fertility history and use of antidepressant medication in late mid-life: a register-based analysis of Norwegian women and men. Aging & mental health. 2015:1-10. doi: 10.1080/13607863.2015.1118010

Lund IO, Skurtveit S, Handal M. Commentary on Raitasalo et al: the great potential in nation-wide registers to study prescription drug use and abuse. Addiction (Abingdon, England). 2015;110(4):644-5. DOI: 10.1111/add.12856

Lund IO, Bukten A, Storvoll EE, Moan IS, Skurtveit S, Handal M, Nordfjaern T, Brunborg GS, Rossow I. A Cohort Study on Long-Term Adverse Effects of Parental Drinking: Background and Study Design. Subst Abuse. 2015 Dec 15;9(Suppl 2):77-83. doi: 10.4137/SaRt.S23329.

Mahic M, Fredheim OM, Borchgrevink PC, Skurtveit S. Use of prescribed opioids by children and adolescents: Differences between Denmark, Norway and Sweden. Eur J Pain. 2015 Sep;19(8):1095-100. doi: 10.1002/ejp.632.

 

Magnus MC, Håberg SE, Karlstad O, Nafstad P, London SJ, Nystad W. Grandmother's smoking when pregnant with the mother and asthma in the grandchild: the Norwegian Mother and Child Cohort Study. Thorax. 2015;70(3):237-43.  doi: 10.1136/thoraxjnl-2014-206438.

 

Neutel CI, Johansen HL. Association between hypnotics use and increased mortality: causation or confounding? European Journal of Clinical Pharmacology. 2015;71(5):637-42.  doi: 10.1007/s00228-015-1841-z.

Rossow I, Bramness JG. The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study. BMC Public Health. 2015;15. doi: 10.1186/s12889-015-1615-7.

Ruths S, Bakken MS, Ranhoff AH, Hunskaar S, Engesaeter LB, Engeland A. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatrics. 2015;15.  doi: 10.1186/s12877-015-0154-5

Skrede S, Tvete IF, Tanum L, Steen VM, Bramness JG. Incident Users of Antipsychotic Agents and Future Use of Cholesterol-Lowering Drugs: An Observational, Pharmacoepidemiologic Study. Journal of Clinical Psychiatry. 2015;76(1):E111-E6. doi: 10.4088/JCP.14m08996.

Suhrke P, Zahl PH. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: A register-based cohort study. Cancer Medicine. 2015;4(8):1303-8. doi:  10.1002/cam4.474

Tvete IF, Bjørner T, Skomedal T. Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway. Scand J Primary Health Care. 2015;33(4):252-9. doi: 10.3109/02813432.2015.1117282

Øymar K, Mikalsen IB, Furu K, Nystad W, Karlstad Ø. Prescription patterns of inhaled corticosteroids for preschool children - A Norwegian register study. Pediatric Allergy and Immunology. 2015;26(7):655-61.  doi: 10.1111/pai.12429

Zoega H, Kieler H, Nørgaard M, Furu K, Valdimarsdottir U, Brandt L, et al. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden. Plos One. 2015;10(12). DOI: 10.1371/journal.pone.0144474

2014

Andersen JB, Heldal AT, Engeland A, Gilhus NE.  Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand Suppl. 2014;129:26-31

Andersen JB, Owe JF, Engeland A, Gilhus NE.  Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study. Eur J Neurol 2014;21:948-955

Bakken MS, Engeland A, Engesæter LB, Ranhoff AH, Hunskaar S, Ruths S. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol 2014;70:873-880

Berg-Hansen P, Moen S, Harbo H, Celius E. High prevalence and no latitude gradient of multiple sclerosis in Norway. Mult Scler 2014;20:1780-1782

Ferrer P, Rafaniello C, Sabate M, Ballarin E, Coma A, Zara C, et al. Cross-national comparison of antiepileptic drug use: Catalonia, Denmark and Norway, 2007-2011. Epidemiology Biostatistics and Public Health. 2014;11:e9405–1.

Fredheim OM, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC. Chronic pain and use of opioids: a population based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trøndelag health study (HUNT). Pain 2014;155:1213-1221

Gjelsvik B, Heyerdahl F, Lunn D, Hawton K. Change in access to prescribed medication following an episode of deliberate self-poisoning: a multilevel approach. PLoS One. 2014;e98086.

Grytli HH, Fagerland MW, Fosså SD, Taskén KA. Association Between Use of b-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. European Urology 2014;65:635-641.

Halvorsen T, Martinussen PE. The geography of chronic obstructive pulmonary disease: A population-based study of Norway. Soc Sci Med 2014;21:25-34.

Jensen ET, Daniels JL, Sturmer T, Robinson WR, Williams CJ, Moster D, et al. Maternal hormonal contraceptive use and offspring overweight or obesity. Int J Obes. 2014;38:1275–81.

Kalseth J, Halvorsen T, Kalseth B, Sarheim Anthun K, Peltola M, Kautiainen K, Häkkinen U, Medin E, Lundgren J, Rehnberg C, Másdóttir BB, Heimisdottir M, Bjarnadóttir HH, Køtlum JE, Kilsmark J, Halsteinli V. Cross-country comparisons of health-care costs: The case of cancer treatment in the Nordic countries. Health Policy 2014:115;172-179.

Kann IC, Lundqvist C, Luras H. Prescription of addictive and non-addictive drugs to home-dwelling elderly. Drugs Aging. 2014 Jun;31(6):453–9.

Karlstad Ø, Furu K, Skurtveit S, Selmer R. Prescribing of Drugs for Attention-Deficit Hyperactivity Disorder in Opioid Maintenance Treatment Patients in Norway. Eur Addict Res 2014;20:59-65.

Kieler H, Malm H, Artama M, Engeland A, Furu K, Gissler M, et al. Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG. 2014 Nov 14;[Epub ahead of print]:doi: 10.1111/1471–0528.13164.

Kielland KB, Amundsen EJ, Dalgard O. HCV treatment uptake in people who have injected drugs - observations in a large cohort that received addiction treatment 1970-1984. Scand J Gastroenterol. 2014 Dec;49(12):1465–72.

Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbaek G. Short- and Long-Term Mortality Risk Associated with the Use of Antipsychotics Among 26,940 Dementia Outpatients: A Population-Based Study. Am J Geriatr Psychiatry 2014;22:321-331.

Mahic M, Fredheim OM, Borchgrevink PC, Skurtveit S. Use of prescribed opioids by children and adolescents: Differences between Denmark, Norway and Sweden. Eur J Pain. 2014 Nov 20;[Epub ahead of print]: doi 10.1002/ejp.632.

Mellbye A, Karlstad O, Skurtveit S, Borchgrevink PC, Fredheim OM. Co-morbidity in persistent opioid users with chronic non-malignant pain in Norway. Eur J Pain. 2014;18:1083-1093

Neutel CI, Skurtveit S, Berg C, Sakshaug S. Trends in prescription of strong opioids for 41-80 year old Norwegians, 2005-2010. Eur J Pain. 2014 Mar;18(3):438–46.

Nordfjærn T, Bjerkeset O, Bratberg G, Moylan S, Berk M, Grawe R. Socio-demographic, lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns. Nord J Psychiatry 2014;68:107-116.

Norum J, Olsen AI, Nohr FI, Heyd A, Totth A. Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study. Glob J Health Sci. 2014 Jul;6(4):155–62.

Omland G, Ruths S, Diaz E. Use of hormonal contraceptives among immigrants and native women in Norway: data from the Norwegian Prescription Database. BJOG 2014;121:1221-1228

Riska BS, Skurtveit S, Furu K, Engeland A, Handal M. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. Eur J Clin Pharmacol. 2014 Nov;70(11):1367–74.

Skrivarhaug T, Stene LC, Drivvoll AK, Strom H, Joner G. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 2014;57:57-62.

Skurtveit S, Selmer R, Odsbu I, Handal M. Self-reported data on medicine use in the Norwegian mother and child cohort study compared to data from the Norwegian prescription database. Norsk Epidemiologi. 2014;24(1-2).

Strøm H, Selmer R, Birkeland KI, Schirmer H, Berg TJ, Jenum AK, et al. No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study. BMC Public Health. 2014;14:520.

Svendsen K, Fredheim OM, Romundstad P, Borchgrevink PC, Skurtveit S. Persistent opioid use and socio-economic factors: a population-based study in Norway. Acta Anaesthesiol Scand. 2014;58:437-445.

Søraas A, Sundsfjord A, Jørgensen SB, Liestøl K, Jenum PA. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. PLoS One. 2014:9;e85889.

2013

Bakken MS, Engeland A, Engesaeter LB, Ranhoff AH, Hunskaar S, Ruths S. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age Ageing 2013;42:514-20.

Berge LI, Riise T, Iversen M. Co-morbidity between diabetes, migraine and depression. Norsk Epidemiologi 2013;23:2013.

Berge LI, Riise T, Fasmer OB, Hundal O, Oedegaard KJ, Midthjell K, et al. Does diabetes have a protective effect on migraine? Epidemiology 2013;24:129-34.

Bjorner T, Tvete IF, Aursnes I, Skomedal T. [Dispensing of benzodiazepines and Z drugs by Norwegian pharmacies 2004-2011]. Tidsskr Nor Laegeforen 2013;133:2149-53.

Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, et al. Antidepressants to cancer patients during the last year of life--a population-based study. Psychooncology 2013;22:506-14.

Devold HM, Sogaard AJ, Tverdal A, Falch JA, Furu K, Meyer HE. Hip fracture and other predictors of anti-osteoporosis drug use in Norway. Osteoporos Int 2013;24:1225-33.

Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, et al. Effects of preconceptional paternal drug exposure on birth outcomes: Cohort study of 340000 pregnancies using Norwegian population-based databases. British Journal of Clinical Pharmacology 2013;75:1134-41.

Fossum GH, Lindbaek M, Gjelstad S, Dalen I, Kvaerner KJ. Are children carrying the burden of broad-spectrum antibiotics in general practice? Prescription pattern for paediatric outpatients with respiratory tract infections in Norway. BMJ Open 2013;3:e002285.

Fredheim OM, Borchgrevink PC, Mahic M, Skurtveit S. A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: a study from the Norwegian Prescription Database. Pain 201;154:2487-93.

Holdø I, Handal M, Skurtveit S, Bramness JG. Association between prescribing hypnotics for parents and children in Norway. Arch Dis Child 2013;98:732-6.

Hoye S, Gjelstad S, Lindbaek M. Effects on antibiotic dispensing rates of interventions to promote delayed prescribing for respiratory tract infections in primary care. Br J GenPract. 2013;63:e777–86.

Jonasson C, Tvete IF, Hatlebakk JG. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study. Scand J Gastroenterol 2013;48:1010-7.

Klovstad H, Natas O, Tverdal A, Aavitsland P. Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial. BMC Infectious Diseases 2013;13:30.

Kravdal O. The poorer cancer survival among the unmarried in Norway: Is much explained by comorbidities? Social Science and Medicine 2013;81:42-52.

Kvaale MK, Grave K, Kristoffersen AB, Norstrom M. The prescription rate of antibacterial agents in dogs in Norway - geographical patterns and trends during the period 2004-2008. J Vet Pharmacol Ther 2013;36:285-91.

Kyrdalen AE, Dahl AA, Hernes E, Smastuen MC, Fossa SD. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer. BJU Int 2013;111:221-32.

Lillefjell M, Haugan T, Martinussen P, Halvorsen T. Treatment outcomes among individuals in a musculoskeletal pain rehabilitation program related to the prevalence and trends in the dispensing of prescribed medications. Journal of Musculoskeletal Pain 2013;21:311-319.

Log T, Skurtveit S, Selmer R, Tverdal A, Furu K, Hartz I. The association between prescribed opioid use for mothers and children: a record-linkage study. Eur J Clin Pharmacol 2013;69:111-8.

Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M. Prescription drug use among pregnant women in opioid Maintenance Treatment. Addiction 2013;108:367-76.

Mauseth SA, Skurtveit S, Spigset O. Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database. Acta Obstet Gynecol Scand 2013;92:1208-1215.

Neutel CI, Skurtveit S, Berg C, Sakshaug S. Multiple prescribers in older frequent opioid users--does it mean abuse? J Popul Ther Clin Pharmacol 2013;20:e397-e405.

Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol 2013;28:759-69.

Nordeng H, Lupattelli A, Romøren M, Koren G. Neonatal outcomes after gestational exposure to nitrofurantoin. Obstetrics and Gynecology 2013;121:306-13.

Nordfjaern T, Bjerkeset O, Moylan S, Berk M, Grawe RW. Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study. Addict Behav 2013;38:2575-80.

Nordfjaern T. Prospective associations between benzodiazepine use and later life satisfaction, somatic pain and psychological health among the elderly. Hum Psychopharmacol 2013;28:248-57.

Persheim MS, Helland A, Spigset O, Slordal L. Potensielt vanedannende legemidler på blåresept ved kroniske sterke smerter. [Potentially addictive drugs on reimbursable prescription for chronic severe pain]. Tidsskrift for den Norske Laegeforening 2013;133:150-4.

Rognstad S, Brekke M, Fetveit A, Dalen I, Straand J. Prescription peer academic detailing to reduce inappropriate prescribing for older patients: a cluster randomised controlled trial. Br J GenPract. 2013;63:e554–62.

Skogar O, Nilsson M, Tornhage CJ, Lokk J. National surveys: a way to manage treatment strategies in Parkinson's disease? Pharmaceutical prescribing patterns and patient experiences of symptom control and their impact on disease. J Multidiscip Healthc 2013;6:239-47.

Skollerud LM, Fredheim OM, Svendsen K, Skurtveit S, Borchgrevink PC. Laxative prescriptions to cancer outpatients receiving opioids: A study from the Norwegian prescription database. Supportive Care in Cancer 2013;21:67-73.

Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M. Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations. J Clin Epidemiol 2013;66:964-72.

Stene LE, Jacobsen GW, Dyb G, Tverdal A, Schei B. Intimate partner violence and cardiovascular risk in women: A population-based cohort study. Journal of Women's Health 2013;22:250-8.

Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013;309:48-54.

Thelle DS, Selmer R, Gjesdal K, Sakshaug S, Jugessur A, Graff-Iversen S, et al. Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women. Heart 2013;99:1755-60.

Tvete IF, Bjorner T, Aursnes IA, Skomedal T. A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing. BMJ Open 2013;3:e003296.

Westin AA, Bramness JG, Chalabianloo F, Rygnestad T, Slordal L. [Pregabalin should be moved to the prescription group B]. Tidsskr Nor Laegeforen 2013;133:615-6.

2012

Berge LI, Riise T, Fasmer OB, Lund A, Oedegaard KJ, Hundal O. Risk of depression in diabetes is highest for young persons using oral anti-diabetic agents. Diabet Med 2012;29:509-14.

Blix HS, Hjellvik V. Økt bruk av antibiotika blant 19-åringer i mai. [Increased use of antibiotics among nineteen-year-olds in May]. Tidsskr Nor Laegeforen 2012;132:1084-8.

Blix HS, Landmark K, Selmer R, Reikvam Å. Forskrivning av antihypertensive legemidler 1975-2010. [Patterns in the prescription of antihypertensive drugs in Norway, 1975 – 2010] Tidsskr Nor Laegeforen 2012;132:1224-8.

Bramness JG, Furu K, Skurtveit S, Engeland A. Effect of withdrawal of carisoprodol on use of other prescribed drugs with abuse potential. Clin Pharmacol Therap 2012;91:438-41.

Bramness JG, Skurtveit S, Mørland J, Engeland A. An increased risk of motor vehicle accidents after prescription of methadone. Addiction 2012;107:967-72.

Devold H, Furu K, Skurtveit S, Tverdal A, Falck JA, Søgård AJ. Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway. Pharmacoepidemiol Drug Saf 2012;21:297-304.

Devold HM, Søgaard AJ, Tverdal A, Falch JA, Furu K, Meyer HE. Hip fracture and other predictors of anti-osteoporosis drug use in Norway. Osteoporosis International 2012;24:1225-33.

Fasmer OB, Riise T, Lund A, Dilsaver SC, Hundal O, Ødegaard KJ. Comorbidity of migraine with ADHD. J Attend Disord 2012;16:339-45.

Fredheim OMS, Moksnes K, Borchgrevink PC, Skurtveit S. Opioid switching to methadone: A pharmacoepidemiological study from a national prescription database. Palliative Medicine 2012;26:804-12.

Fredheim OM, Moksnes K, Borchgrevink PC, Skurtveit S. Opoid switching to methadone: a pharmacoepidemiological study from a national prescription database. Palliat Med 2012;26;804-812.

Gedde-Dahl A, Devold HM, Molden E. Statin medication in patients treated with antiepileptic drugs in Norway. Pharmacoepidemiol Drug Saf 2012;21:881-5.

Gjelsvik B, Heyerdahl F, Hawton K. Prescribed medication availability and deliberate self-poisoning: a longitudinal study. J Clin Psychiatry. 2012;73:e548-54.

Handal M, Skurtveit S, Mørland JG. Samtidig bruk av ulike benzodiazepiner. [Co-medication with benzodiazepines]. Tidsskr Nor Laegeforen. 2012;132:526-30.

Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S. Hypnotic drug use among 0-17 year olds during 2004-2011: A nationwide prescription database study. Scandinavian Journal of Public Health 2012;40:704-11.

Hjellvik V, Mahic M, Tverdal A. Utdanning og legemiddelbruk. [Education and use of drugs in Norway]. Tidsskr Nor Laegeforen 2012;132:2166-70.

Karlstad Ø, Nafstad P, Tverdal A, Skurtveit S, Furu K. Comorbidities in an asthma population 8-29 years old: A study from the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2012;21:1045-52.

Kieler H, Artama M, Engeland A, Ericsson O,Furu K,Gissler M, Nørgaard M, Nielsen RB, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B. Selective serotonin-reuptake inhibitors during pregnancy and risks of persistent pulmonary hypertension of the newborn: population based cohort study from the five Nordic countries BMJ 2012;344:d8012.

Kjome RL, Roraas T, Granas AG, Sandberg S. [Regional differences in sales of glucometer strips and antidiabetics]. Tidsskr Nor Laegeforen 2012;132:1453-7.

Kjosavik SR, Ruths S, Hunskår S. Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway. Eur J Clin Pharmacol 2012;68:311-9.

Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J. The HUNT study: Participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC Medical Research Methodology 2012;12:143.

Lillemoen PKS, Kjosavik SR, Hunskår S, Ruths S. [Prescriptions for ADHD medication, 2004 – 08]. Tidsskr Nor Laegeforen 2012;132:1856-60.

Mellbye A, Svendsen K, Borchgrevink PC, Skurtveit S, Fredheim OMS. Concomitant medication among persistent opioid users with chronic non-malignant pain. Acta Anaesthesiologica Scandinavica 2012;56:1267-76.

Neutel CI, Skurtveit S, Berg C. What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Medicine 2012;13:893-7.

Neutel I, Skurtveit S, Berg C. Polypharmacy of potentially addictive medication in the older persons - quantifying usage. Pharmacoepidemiol Drug Saf 2012;21:199-206

Neutel CI, Skurtveit S, Berg C. Benzodiazepine and z-hypnotic use in Norwegian elderly, aged 65-79. Norsk Epidemiologi 2012;22:203-8.

Nordbø A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM. Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs. Acta Anaesthesiol Scand. 2012;56:88-94.

Nordfjærn T. A population-based cohort study of anxiety, depression, sleep and alcohol outcomes among benzodiazepine and z-hypnotic users. Addictive Behaviors 2012;37:1151-7.

Nyborg G, Straand J, Brekke M. Inappropriate prescribing for the elderly - A modern epidemic? European Journal of Clinical Pharmacology 2012;68:1085-94.

Pedersen L, Hansen AB, Svendsen K, Skurtveit S, Borchgrevink PC, Fredheim OMS. [Reimbursement of analgesics for chronic pain]. Tidsskr Nor Laegeforen 2012;132:2489-93.

Romoren M, Lindbaek M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. British Journal of Clinical Pharmacology 2012;74:1053-62.

Rønning PA, Helseth E, Meling TR, Johannesen TB. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro-Oncology 2012;14:1178-84.

Selmer R, Blix HS, Landmark K, Reikvam Å. Choice of initial antihypertensive drugs and persistence of drug use--a 4-year follow-up of 78,453 incident users. Eur J Clin Pharmacol 2012;68:1435-42.

Skjeldestad FE. [Prescribing contraception for young women]. Tidsskr Nor Laegeforen. 2012;132:292-4.

Steffenak AKM, Wilde-Larsson B, Skurtveit S, Furu K, Nordström G, Hartz I. Mental distress and subsequent use of psychotropic drugs among adolescents - a prospective register linkage study. J Adolescent Health 2012;50:578-87

Steffenak AKM, Wilde-Larsson B, Nordstrom G, Skurtveit S, Hartz I. Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: A nationwide prescription database study. Clinical Epidemiology 2012;4:225-31.

Stene LE, Dyb G, Tverdal A, Jacobsen GW, Schei B. Intimate partner violence and prescription of potentially addictive drugs: prospective cohort study of women in the Oslo Health Study. BMJ Open. 2012 Apr 5;2(2):e000614.

Svendal G, Fasmer OB, Engeland A, Berk M, Lund A. Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study with focus on gender differences. BMC Medicine 2012;10:148.

Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OM. Differential patterns of opioid use: defining persistent opioid use in a prescription database. Eur J Pain 2012;16:359-69.

Viktil KK, Engeland A, Furu K. Outcomes after antirheumatic drug use before and during pregnancy - a cohort study among 150 000 pregnant women and expectant fathers. Scand J Rheum 2012;41:196-201.

Von Soest T, Bramness JG, Pedersen W, Wichstrøm L. The relationship between socio-economic status and antidepressant prescription: A longitudinal survey and register study of young adults. Epidemiology and Psychiatric Sciences 2012;21:87-95.

Åsvold BO, Vatten LJ, Midthjell K, Bjøro T. Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT Study in Norway. J Clin Endocrinol Metab. 2012;97:93-9.

2011

Berg C, Sakshaug S, Handal M, Skurtveit S. Z-hypnotika - Sovemidlene som dominerer markedet i Norge. Norsk Farmaceutisk Tidsskrift 2011;4:20-23.

Blix H, Hjellvik V, Litleskare I, Rønning M, Tverdal A. Cigarette smoking and risk of subsequent use of antibacterials: a follow-up of 365 117 men and women. J Antimicrob Chemother 2011;66:2159-67.

Bramness JG, Sexton JA. The basic pharmacoepidemiology of benzodiazepine use in Norway 2004-9. Norsk Epidemiologi 2011; 21: 35-42

Brekke M, Straand J. Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observation study. BMC Public Health. 2011;11:144.

Dalen DM, Furu K, Locatelli M, Strøm S. Generic substitution: micro evidence from register data in Norway. Eur J Health Econ 2011;12:49-59.

Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230.000 women in Norway. Eur J Epidemiol 2011;26:157-63.

Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2011;20:243-8.

Fasmer OB, Riise T, Eagan TM, Lund A, Dilsaver SC, Hundal Ø, Ødegaard KJ. Comorbidity of asthma with ADHD. J Atten Disord 2011;15:564-71.

Fredheim OM, Borchgrevink P, Nordstrand B, Clausen T, Skurtveit S. Prescription of analgesics to patients in opioid maintenance therapy: A pharmacoepidemiological study.  Drug Alcohol Depend 2011;116:158-62.

Furu K, Karlstad Ø, Skurtveit S, Håberg SE, Nafstad P, London SJ, Nystad W. High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database. J Clin Epidemiol 2011;64:878-84.

Furu K, Skurtveit S. Legemidler forskrevet til barn og ungdom i alderen 0-17 år i Norge. En studie basert på data fra Reseptregisteret. Norsk Farmaceutisk Tidsskrift 2011;119:14-7.

Ghaderi S, Nordbø SA, Bakken IJ. Chlamydiainfeksjon i Sør-Trøndelag – behandling og oppfølging. [Chlamydia infections in South Trøndelag – treatment and follow-up]. Tidsskr Nor Laegeforen 2011;131:461-3.

Godman B, Sakshaug S, Berg C, Wettermark B, Haycox A. Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs. Expert Rev Pharmacoecon Outcomes Res. 2011;11:121-9.

Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, Lonsdale J, Malmström R, Martikainen J, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay F, Vlahovic-Palcevski V, Wendykowska K, Wettermark B, Zara Corinne Gustafsson L. Policies to enchance prescribing effiency in Europe: findings and future implications. Front Pharmacol 2011;1:141.

Gjelstad S, Straand J, Dalen I, Fetveit A, Strøm H, Lindbæk M. Do general practitioners’ consultation rates influence their prescribing patterns of antibiotics for acute respiratory tract infections? J Antimicrob Chemother 2011;66:2425-33.

Hancock D, Håberg SE, Furu K, Whitworth KV, Nafstad P, Nystad W, London SJ. Oral contraceptive pill use before pregnancy and respiratory outcomes in early childhood. Pediatr Allergy Immunol 2011;22:528-36.

Handal M, Engeland A, Rønning M, Skurtveit S, Furu K. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during and after pregnancy. A population based cohort study. Eur J Clin Pharmacol 2011;67:953-60

Harman C, Reid M, Thomas KV.In situ calibration of a passive sampling device for selected illicit drugs and their metabolites in wastewater, and subsequent year-long assessment of community drug usage. Environ Sci Technol. 2011;45:5676-82.

Hartz I, Bramness JG, Skurtveit S. Prescription of antidepressants to patients on opioid maintenance therapy – a pharmacoepidemiological study Norsk Epidemiologi 2011;21:77-83.

Hartz I, Tverdal, Aa, Skurtveit S. Langtidsbruk av benzodiazepiner i kombinasjon med opioider og z-hypnotika blant uføretrygdede i Norge. Norsk Farmaceutisk Tidsskrift 2011; 119, 24-28

Hjellvik V, Tverdal A, Strøm H. Boiled coffee intake and subsequent risk for Type 2 Diabetes. Epidemiology 2011;22:418-21.

Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S. Breast cancer incidence trends in Norway –explained by hormone therapy or mammographic screening? International Journal of Cancer 2011;95:51-9.

Karlstad Ø, Tverdal A, Skurtveit S, Nafstad P, Furu K. A prospective study of asthma and subsequent use of hypnotics in young adults. Pharmacoepidemiol Drug Saf 2011;20:370-7

Kjosavik SR, Hunskaar S, Aarsland D, Ruths S. Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway. Acta Psychiatr Scand 2011;123:459-65.

Kvaale MK, Grave K, Bangen M, Norström M. Forskrivning av antibakterielle midler til hund og katt i Norge i perioden 2005-2008. Norsk Veterinærtidsskrift 2011;123:76-79.

Landmark CJ, Fossmark H, Larsson PG, Rytter E, Johannessen SI. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res. 2011;95:51-9.

Langballe EM, Engdahl B, Selbaek G, Nordeng H. Concomitant use of anti-dementia drugs with psychotropic drugs in Norway--a population-based study. Pharmacoepidemiol Drug Saf. 2011;20:1319-26

Log T, Hartz I, Handal M, Tverdal A, Furu K, Skurtveit S. The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults – a population-based cohort study. Pharmacoepidemiol Drug Saf 2011;20:90-8.

Log T, Skurtveit S, Tverdal A, Furu K, Hartz I. Dispensing of prescribed analgesics in Norway among young people with foreign- or Norwegian-born parents. Scand J Pain 2011;2:36-44.

Mahic M, Skurtveit S, Selmer R, Rønning M, Furu K. Prevalence, incidence and persistence of etanercept and adalimimab in Norway 2005-2009. Pharmacoepidemiol Drug Saf. 2011;20:457-63.

Neubert A, Hsia Y, de Jong-van den Berg LT, Janhsen K, Glaeske G, Furu K, Kieler H, Nørgaard M, Clavenna A, Wong IC. Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol. 2011;72:969-77.

Skurtveit S, Furu K, Handal M, Borchgrevink P, Fredheim O. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain 2011;152:1555-61.

Zoega H, Furu K, Halldórsson M, Thomsen PH, Sourander A, Martikainen JE.Use of ADHD drugs in the Nordic countries: A population-based comparison study. Acta Psychiatr Scand 2011;123:360-7.

Ødegaard KJ, Dilsaver SC, Hundal O, Riise T, Lund A, Akiskal HS, Fasmer OB. Are migraine and bipolar disorders comorbid phenomena?: findings from a pharmacoepidemiological study using the Norwegian Prescription Database. J Clin Psychopharmacol. 2011;31:734-9.

Ødegaard KJ, Riise T, Dilsaver S, Lund A, Akiskal H, Fasmer OB, Hundal Ø. A pharmaco-epidemiological study of migraine and antidepressant medications: Complete one year data from the Norwegian population. J Affective Disorders 2011;129:198-204.

2010

Amundsen MO, Engdahl B, Berg C, Nordeng H. Cardiovascular co-medication among users of antiobesity drugs: a population-based study. Pharm World Sci. 2010;32:752-8.

Amundsen MO, Engdahl B, Berg C, Nordeng H. Use of psychotropic drugs and analgesics among users of antiobesity drugs--a population based study. Pharmacoepidemiol Drug Saf 2010;19:273-9.

Andersen JB, Engeland A, Owe JF, Gilhus NE. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. Eur J Neurol 2010;17:1445-50.

Berg A, Furu K, Einen, M, Spigseth O: Bør barn behandles med efedrin mikstur? [Should children be treated with ephedrine mixture?].  Tidsskr Nor Lægeforen 2010;24: 2474-5.

Berge HM, Gjelstad S, Furu K, Straand J. Glukosaminbruk reduserer ikke behovet for analgetika [Use of glucosamine does not reduce the need for other pain-relieving drugs]. Tidsskr Nor Laegeforen 2010;130:1463-6.

Bramness JG, Rossow I. Can the total consumption of a medicinal drug be used as an indicator of excessive use? The case of carisoprodol. Drugs: Education, Prevention, and Policy 2010;17:168-80

Bramness J, Sandvik P, Engeland A, Skurtveit S. Does pregabalin (Lyrica) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database. Basic Clin Pharmacol Toxicol 2010;107:883-6

Devold HM, Doung GM, Tverdal A, Furu K, Meyer HE, Falch JA, Søgaard AJ. Prescription of anti-osteoporosis drugs during 2004-2007 – a nationwide register study in Norway. Eur J Clin Pharmacol 2010;66:299-306.

Fredheim OM, Skurtveit S, Breivik H, Borchgrevink P. Increasing use of opoids from 2004 to 2007 – Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010;14:289-294.

Fredheim OM, Log T, Olsen W, Skurtveit S, Sagen Ø, Borchgrevink P. Prescription of opioids to children and adolescents; a study from a national prescription database in Norway. Pediatric Anesthesia 2010;20:537-544.

Furu K, Skurtveit S, Strøm H, Rønning M. Reseptregisteret 2004-2009 - en kilde til informasjon. Norsk Farmaceutisk Tidsskrift 2010;12:29-31.

Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic Countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010;106:86-94. 

Gjerden P, Slørdal L, Bramness JG. Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up. Eur J Clin Pharmacol 2010;66:911-7.

Hartz I, Tverdal A, Skille E, Skurtveit S. Disability pension as a predictor of later use of benzodiazepines among benzodiazepines users. Soc Sci Med 2010;70:921-5.

Hausken AM, Furu K, Tverdal A, Skurtveit S. Mental distress and subsequent use of anxiolytic drugs - a prospective population-based cohort study of 16 000 individuals. Scand J Public Health 2010;38:465-73.

Hjellvik V, Tverdal A, Furu K. Body mass index as predictor for asthma: a cohort study of 118 723 males and females. Eur Resp J 2010;35:1235-42.

Hunskaar S, Welle-Nilsen LK. The market lifecycle of duloxetine for urinary incontinence in Norway. Acta Obstet Gynecol Scand. 2010;89:217-22

Kann IC, Biørn E, Lurås H. Competition in general practice: prescriptions to the elderly in a list patient system. J Health Econ. 2010;29:751-64

Karlstad Ø, Nafstad P, Tverdal A, Skurtveit S, Furu K. Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study. Eur J Clin Pharmacol 2010;66:399-406.

Karouni M, Arulthas S, Larsson PG, Rytter E, Johannessen SI, Landmark CJ. Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 2010;66:1151-60.

Kjome RL, Granas AG, Nerhus K, Roraas TH, Sandberg S. The prevalence of self-monitoring of blood glucose and costs of glucometer strips in a nationwide cohort. Diabetes Technol Ther 2010;12:701-5.

Kornør H, Pedersen W, von Soest T, Rossow I, Bramness JG. Bruk av benzodiazepiner og cannabis blant unge voksne [Use of benzodiazepines and cannabis in young adults]. Tidsskr Nor Laegeforen 2010 ;130:928-31.

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A. Benzodiazepines predict use of opioids– a follow-up study of 17 074 men and women. Pain Med 2010;11:805-14.

Skurtveit S, Furu K, Selmer R, Handal M, Tverdal A. Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study. Ann Epidemiol 2010;20:890-7.

Vandraas K, Spigset O, Mahic M, Slørdal S. Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly. Eur J Clin Pharmacol 2010;66:823-9.

2009

Bachs LC, Engeland A, Mørland JG, Skurtveit S. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clin Pharmacol Ther 2009;85:596-9.

Bramness JG. Bruk av litium i Oslo og i Sogn og Fjordane [Use of lithium in the Norwegian counties Oslo and Sogn og Fjordane]. Tidsskr Nor Laegeforen 2009;129:855-7.

Bramness JG. Ungdom og dagliglivets smerter. [Adolescents and everyday life pains]. Tidsskr Nor Laegeforen 2009; 129:1444.

Bramness JG, Grøholt B, Engeland A, Furu K. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 – a prescription database study. J Affect Disord 2009; 117:208-11.

Bramness JG, Skurtveit S, Neutel I, Mørland J, Engeland A. An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiol Drug Saf 2009;18:492-6.

Bramness JG, Weitoft GR, Hallas J. Use of lithium in the adult populations of Denmark, Norway and Sweden. J Affect Disord 2009;118:224-8.

Devold H, Molden E, Skurtveit S, Furu K. Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy. Brit J Clin Pharmacol 2009;67:234-41.

Engeland A, Bjørge T, Daltveit AK, Vollset SE, Furu K. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009;88:1083-9.

Fredheim OM, Skurtveit S, Moroz A, Breivik H, Borchgrevink P. Prescription pattern of codeine for non-malignant pain in Norway- a pharmacoepidemiological study from The Norwegian Prescription Database. Acta Anaesthesiol Scand 2009;53:627-33.

Gjerden P, Bramness JG, Slørdal L. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2009;67:228-33.

Gjerden P, Slørdal L, Bramness JG. Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents. Eur J Clin Pharmacol 2009;65:1229-35.

Gjerden P, Slørdal L, Bramness JG. The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine. Br J Clin Pharmacol 2009;68:238-42.

Hartz I, Lundesgaard E, Tverdal A, Skurtveit S. Disability pension is associated with the use of benzodiazepines 20 years later: A prospective study. Scand J Public Health 2009;37:320-6.

Hartz I, Tverdal A, Skurtveit S. A comparison of self-reported data on disability pension status with data from a nationwide administrative register. Nor J Epidemiol 2009;19:169-172.

Hartz I, Tverdal A, Skurtveit S. Social inequalities in use of potentially addictive drugs in Norway – use among disability pensioners. Nor J Epidemiol 2009;19:209-218.

Hauge S, Blix HS, Borgen K, Hungnes O, Dudman SG, Aavitsland P. Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08. Virol J 2009;6:54.

Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. Eur J Clin Pharmacol 2009;65:295-301.

Håkonsen GD, Pettersen MH, Skurtveit S, Giverhaug T. Samtidig bruk av warfarin, analgetika og antiinflammatoriske midler. [Concomitant use of warfarin, analgesics and anti-inflammatory drugs]. Tidsskr Nor Laegeforen 2009;129:1217-20.

Kjosavik SR, Ruths S, Hunskaar S. Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database Pharmacoepidemiol Drug Saf 2009;18:572-8.

Landmark CJ, Larsson P, Rytter E, Johannessen SI. Antiepileptic drugs in epilepsy and other disorders - a population-based study of prescriptions. Epilepsy Res 2009; 87: 31-9.

Selmer R, Sakshaug S, Skurtveit S, Furu K, Tverdal A. Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education. Brit J Clin Pharmacol 2009;67:355-62.

Skurtveit S, Furu K, Kaasa S, Borchgrevink P. Introduction of low dose transdermal buprenorphine - did it influence use of potentially addictive drugs in chronic non-malignant pain patients? Eur J Pain 2009;13:949-53.

Skurtveit S, Strøm H, Skrivarhaug T, Mørland J, Bramness J, Engeland A. Road traffic accident risk in patients with diabetes mellitus, receiving blood glucose-lowering drugs. Prospective follow-up study. Diabet Med 2009; 26:404-08.

Viktil K, Engeland A, Furu K. Use of antirheumatic drugs in mothers and fathers before and during pregnancy – a population-based cohort study Pharmacoepidemiol Drug Saf 2009;18:737-42.

Winther RB, Bramness JG. Legemiddelshopping av vanedannende medikamenter i Norge [Prescription shopping of addictive drugs in Norway]. Tidsskr Nor Laegeforen  2009;129:517-20.

2008

Bachs LC, Bramness JG, Engeland A, Skurtveit S. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Nor J Epidemiol 2008;18:185-90.

Berg A, Furu K, Spigset O. Slimhinneavsvellende nesedråper og nesespray hos barn [Nasal decongestants and nasal sprays in children].Tidsskr Nor Laegeforen 2008;128:2582-3.

Bramness JG, Buajordet I, Skurtveit S. The role of pharmacoepidemiological studies in the market withdrawal of carisoprodol (Somadril®) in Europe. Nor J Epidemiol 2008;18:167-72.

Bramness JG, Skurtveit S. Carisoprodol should be taken of the market. South Med J 2008;101:1074-5.

Bramness JG , Skurtveit S, Neutel CI, Mørland J, Engeland A. Minor increase in risk of road traffic accidents after prescriptions of antidepressants. J Clin Psych 2008; 69:1099-1103.

Brekke M, Rognstad, Straand J, Furu K, Gjelstad S, Bjørner T, Dalen I. Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Baseline data from The Prescription Peer Academic Detailing (Rx-PAD) study. Scand J Prim Health Care 2008;26:80-5.

Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription druguse among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-06. Br J Clin Pharmacol 2008;65:653-60.

Engeland A, Bramness JG, Mørland J, Skurtveit S. Veitrafikkulykker knyttet til forskrivning av legemidler: en registerbasert kohortstudie. [Traffic accident risks associated with the prescription of medicinal drugs: a registry-based cohort study] Nor J Epidemiol 2008;18: 159-66.

Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - New opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 2008; 18:129-36.

Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel CI, Mørland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008;9:818-22.

Hagen K. Stovner LJ. Skorpen F. Pettersen E. Zwart JA. COMT genotypes and use of antipsychotic medication: linking population-based prescription database to the HUNT study. Pharmacoepidemiol Drug Saf 2008;17:372-7.

Litleskare I, Blix H, Rønning M. Antibiotikaforbruk i Norge [Antibiotic use in Norway]. Tidsskr Nor Laegeforen 2008;128:2324-9.

Olsen AS, Ottesen S. Varierende forskrivning av opioider til norske kreftpasienter [Variable prescription of opioids to cancer patients in Norway]. Tidsskr Nor Laegeforen 2008;128:1271-4.

Skurtveit S, Furu K, Bramness JG, Tverdal A. Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later – a follow-up study of 13 390 men and women aged 40-42 years. Pharmacoepidemiol Drug Saf 2008;17:926-933.

Skurtveit S, Selmer R, Tverdal A, Furu K. The validity of self-reported prescription medication use among adolescents varied by therapeutic class. J Clin Epidemiol 2008;61:714-17.

Strøm H, Sakshaug S, Skurtveit S. Use of statins in patients receiving oral blood glucose-lowering drugs. Nor J Epidemiol 2008;18:191-94.

2007

Al-Haroni M, Skaug N. Incidence of antibiotic prescribing in dental practice in Norway and its contribution to national consumption. J Antimicrob Chemother 2007;59:1161-6.

Blix HS, Engeland A, Litleskare I, Rønning M. Age- and gender-specific antibacterial prescribing in Norway. J Antimicrob Chemother 2007;59:971-6.

Bramness JG, Engeland A, Furu K. Antidepressiver hos barn og ungdom – førte advarsler til færre forskrivninger? [The use of antidepressants amongst children and adolescents – did the warnings lead to fewer prescriptions?] Tidsskr Nor Laegeforen 2007;127:2653-5.

Bramness JG, Furu K, Engeland A,  Skurtveit S. Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. Br J Clin Pharmacol 2007;64: 210-8. 

Bramness JG, Kornør H. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend 2007;90:203-9.

Bramness JG, Skurtveit S, Mørland J, Engeland A. The risk of road traffic accidents after prescriptions of carisoprodol. Accid Anal Prev 2007;39:1050-5.

Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of medicinal drugs: a registry-based cohort study. Ann Epidemiol 2007;17:597-602.

Furu K, Skurtveit S, Langhammer A, Nafstad P. Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol 2007;63:693-8.

Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njolstad I, Skurtveit S. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clin Pharmacol 2007;7:14.

Nygard K, Schimmer B, Sobstad O, Walde A, Tveit I, Langeland N, Hausken T, Aavitsland P. A large community outbreak of waterborne giardiasis-delayed detection in a non-endemic urban area. BMC Public Health 2006;6:141.

Sakshaug S, Furu K, Karlstad Ø, Rønning M, Skurtveit S. Switching statins in Norway after new reimbursement policy - a nationwide prescription study. Br J Clin Pharmacol 2007;64:476-81.

Torkildsen O, Grytten N, Myhr KM. Immunomodulatory treatment of multiple sclerosis in Norway. Acta Neurol Scand Suppl 2007;187:46-50.

Åsheim H, Nilsen KB, Johansen K, Furu K.[Prescribing of stimulants for ADHD in Nordland county]. Tidsskr Nor Laegeforen 2007;127:2360-2.

2006

Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M. [Changes in the sale and use of flunitrazepam in Norway, 1999 – 2004]. Tidsskr Nor Laegeforen 2006;126:589-90.

Gjelstad S, Fetveit A, Straand J, Dalen I, Rognstad S, Lindback M. Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice--the Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155]. BMC Health Serv Res 2006;6:75.

Mellingsæter T, Bramness JG, Slørdal L. [Are z-hypnotics better and safer sleeping pills than benzodiazepines?] Tidsskr Nor Laegeforen 2006; 126: 2954-6.

Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice--The Prescription Peer Academic Detailing (Rx-PAD) study [NCT00281450]. BMC Health Serv Res 2006;6:72.

Strøm H, Engeland A, Eriksen E, Sakshaug S, Rønning M. [How many and who are receiving medication for diabetes mellitus?] Tidsskr Nor Laegeforen 2006;126:768-70.

2005

Bramness JG, Hausken AM, Sakshaug S, Skurtveit S, Rønning M. [Prescription of selective serotonin reuptake inhibitors 1990-2004]. Tidsskr Nor Laegeforen 2005;125:2470-3.

2004

Strøm H. Reseptbasert legemiddelregister: Et viktig verktøy for å oppnå detaljert legemiddelstatistikk [The Norwegian Prescription Database: An important tool for detailed information on drug use]. Nor J Epidemiol 2004;14:53-56.

2001

Furu K. Drug utilisation in a public health perspective: Establishing a national prescription register in Norway. Nor J Epidemiol 2001;11:55-60.